The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination
Bibliographic Data
| ID | 14907177 |
|---|---|
| Authors | Jim Young (0000-0002-4314-3007, McGill University Health Centre, corresponding author), Shouao Wang (McGill University Health Centre), Charlotte Lanièce Delaunay (0000-0002-7038-325X, McGill University Health Centre), Curtis Cooper (0000-0002-3368-3499, Ottawa Hospital), Curtis L Cooper, Joseph Cox (0000-0002-7041-1556, McGill University Health Centre), M John Gill (0000-0002-8546-8790, University of Calgary), Mark Hull (0000-0002-9234-3531, St. Paul's Hospital), Sharon Walmsley (0000-0002-3959-5692, University of Toronto), Alexander Wong (0009-0009-9781-5479, University of Saskatchewan), Marina B Klein (0000-0002-3063-8430, McGill University Health Centre) |
| Year | 2023 |
| Volume | 114 |
| Pages | 103981 |
| Publication date | 2023-04-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2023.103981 |
| PMID | 36893502 |
| OpenAlex | W4323350060 |
| Language | EN |
| References cited | 46 |
Cohort · Cohort study · Coinfection · Confidence interval · Hazard ratio · Hepatitis C · Hepatitis C virus · Human immunodeficiency virus (HIV · Interferon · Pathology · Public health · Virus · Demography · Hepatitis B Virus Studies · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Immunology · Internal Medicine · Virology
Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units
Covid just kind of opened a can of whoop-ass”
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada
Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland
| Highly cited | No |
|---|